NCT06966674View on ClinicalTrials.gov

No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 12, 2025

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2025

Conditions
No-ReflowSTEMIIntracoronaryTirofiban
Interventions
DRUG

Intracoronary tirofiban

Patients will receive intracoronary tirofiban (Aggrastat®) (25 mg/kg).

DRUG

Saline 0.9%

Patients will receive intracoronary saline 0.9% solution as a control group.

Trial Locations (1)

33516

RECRUITING

Kafrelsheikh University, Kafr ash Shaykh

All Listed Sponsors
lead

Kafrelsheikh University

OTHER